Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
April 11, 2012
|
April 9, 2012
|
April 9, 2012
|
April 9, 2012
|
|
April 8, 2012
|
March 21, 2012
|
March 9, 2012
|
March 7, 2012
|